IDEXX Laboratories (NASDAQ: IDXX) EVP reports new equity grants and RSU vesting

Rhea-AI Filing Summary

IDEXX Laboratories Executive Vice President Michael Schreck reported a series of equity compensation transactions. On February 12, 2026, he was granted 4,625 non-qualified stock options and 162 incentive stock options, along with 1,094 and 1,620 restricted stock units (RSUs), all at a stated price of 0.0000 per share. Footnotes state these options become exercisable in installments beginning February 14, 2027 and on February 14, 2030, while the RSUs vest over three or four annual installments starting February 14, 2027 and February 14, 2026.

On February 14, 2026, multiple RSU awards vested and were converted into an aggregate of 1,959 shares of common stock at a stated price of 0.0000 per share. In a separate transaction coded “F,” 876 common shares at 629.35 per share were disposed of to satisfy tax withholding, leaving 3,088.709 common shares owned directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schreck Michael

(Last) (First) (Middle)

ONE IDEXX DRIVE

(Street)

WESTBROOK ME 04092

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/14/2026		M		117	A	$0	2,122.709(1)	D
Common Stock	02/14/2026		M		169	A	$0	2,291.709	D
Common Stock	02/14/2026		M		301	A	$0	2,592.709	D
Common Stock	02/14/2026		M		367	A	$0	2,959.709	D
Common Stock	02/14/2026		M		1,005	A	$0	3,964.709	D
Common Stock	02/14/2026		F		876	D	$629.35(2)	3,088.709	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy)	$617.2	02/12/2026		A		4,625		(3)	02/11/2036	Common Stock	4,625	$0	4,625	D
Incentive Stock Option (right-to-buy)	$617.2	02/12/2026		A		162		(4)	02/11/2036	Common Stock	162	$0	162	D
Restricted Stock Unit	(5)	02/12/2026		A		1,094		(5)	(5)	Common Stock	1,094	$0	1,094	D
Restricted Stock Unit	(6)	02/12/2026		A		1,620		(6)	(6)	Common Stock	1,620	$0	1,620	D
Restricted Stock Unit	(7)	02/14/2026		M			117	(7)	(7)	Common Stock	117	$0	0	D
Restricted Stock Unit	(8)	02/14/2026		M			169	(8)	(8)	Common Stock	169	$0	169	D
Restricted Stock Unit	(9)	02/14/2026		M			301	(9)	(9)	Common Stock	301	$0	602	D
Restricted Stock Unit	(10)	02/14/2026		M			367	(10)	(10)	Common Stock	367	$0	1,101	D
Restricted Stock Unit	(11)	02/14/2026		M			1,005	(11)	(11)	Common Stock	1,005	$0	0	D

Explanation of Responses:

1. Includes a total of 49.709 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.

2. Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.

3. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.

4. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.

5. Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027.

6. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in three annual installments, beginning February 14, 2027.

7. Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments beginning February 14, 2023.

8. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning February 14, 2024.

9. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning February 14, 2025.

10. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026.

11. Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2026.

Remarks:

	/s/ Lily J. Lu, Attorney-in-Fact for Michael Schreck	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did IDEXX (IDXX) Executive Vice President Michael Schreck report?

Michael Schreck reported routine equity compensation activity, including option and restricted stock unit grants on February 12, 2026, and RSU vesting on February 14, 2026. Some resulting common shares were withheld and disposed of to cover associated tax obligations, leaving him directly holding 3,088.709 common shares.

How many stock options were granted to IDEXX (IDXX) EVP Michael Schreck?

Schreck received 4,625 non-qualified stock options and 162 incentive stock options on February 12, 2026. Footnotes explain these options become exercisable in scheduled installments beginning February 14, 2027 and in a single installment on February 14, 2030, subject to their respective vesting terms.

What restricted stock unit awards did IDEXX (IDXX) report for Michael Schreck?

On February 12, 2026, Schreck was granted 1,094 and 1,620 restricted stock units. Each RSU represents a contingent right to receive one IDEXX common share and vests in three or four annual installments beginning February 14, 2027 and February 14, 2026, according to the detailed vesting footnotes.

How many IDEXX (IDXX) shares did Michael Schreck acquire through RSU vesting?

On February 14, 2026, several RSU awards vested and were converted into a total of 1,959 IDEXX common shares at a stated price of 0.0000 per share. These conversions reflect previously granted RSUs reaching their vesting dates under the company’s long-term incentive plans.

Why did IDEXX (IDXX) EVP Michael Schreck dispose of 876 shares of common stock?

Schreck disposed of 876 common shares at 629.35 per share in a transaction coded “F.” This code indicates shares were withheld and delivered to satisfy tax liabilities arising from equity vesting, rather than an open-market sale for investment or portfolio reasons.

How many IDEXX (IDXX) shares does Michael Schreck hold after these Form 4 transactions?

Following the reported February 2026 transactions, Schreck directly holds 3,088.709 IDEXX common shares. This figure reflects shares acquired through RSU conversions, reduced by the 876 shares disposed of to cover tax withholding obligations tied to those equity awards.

Are Michael Schreck’s IDEXX (IDXX) equity awards immediately exercisable or fully vested?

No, the newly reported awards vest over time. Option grants begin to become exercisable in annual installments starting February 14, 2027, with one grant exercisable on February 14, 2030. RSU grants vest in three or four annual installments beginning February 14, 2026 and February 14, 2027.